Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Dose-Finding Study of Lu AA24530 in Major Depressive Disorder.
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Tedatioxetine (Primary) ; Duloxetine
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- 30 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.
- 02 Jul 2009 Positive headline results released by Lundbeck.
- 19 Jun 2009 Additional locations identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History